Adial pharmaceuticals chief medical officer and key opinion leaders to discuss “new aspects in substance use treatment” at the annual international society of addiction medicine conference

Charlottesville, va., oct. 31, 2023 (globe newswire) -- adial pharmaceuticals, inc. (nasdaq: adil; adilw) (“adial” or the “company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that the chief medical officer of adial, bankole johnson, d.sc., m.d., and key opinion leaders jonathan chick, m.d., hannu alho, m.d., and icro maremmani m.d., will be presenting at the annual international society of addiction medicine conference taking place november 2-4, 2023, in marrakesh, morocco.
ADIL Ratings Summary
ADIL Quant Ranking